Torrent Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Quarterly Results    (TORR)

Here are the latest quarterly results of Torrent Pharma. For more details, see the Torrent Pharma financial fact sheet and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Torrent Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m20,51018,56020,22020,05019,66019,46020,56020,170 
Other income Rs m301702003405301504060 
Turnover Rs m20,54018,73020,42020,39020,19019,61020,60020,230 
Expenses Rs m14,90013,83014,81014,64014,26013,98013,95013,820 
Gross profit Rs m5,6101,1605,4105,4105,4005,4806,6106,350 
Depreciation Rs m1,5601,6001,6001,6301,6301,6801,6101,650 
Interest Rs m1,3301,2301,2201,1601,1101,0201,020920 
Profit before tax Rs m2,750-1,5002,7902,9603,1902,9304,0203,840 
Tax Rs m29020630520680-210810740 
Profit after tax Rs m2,460-1,5202,1602,4402,5103,1403,2103,100 
Gross profit margin %27.46.326.827.027.528.232.131.5 
Effective tax rate %10.5-1.322.617.621.3-7.220.119.3 
Net profit margin %12.0-8.210.712.212.816.115.615.4 
Diluted EPS Rs 14.5 -9.0 12.8 14.4 14.8 18.6 19.0 18.3  
Diluted EPS (TTM) Rs 48.2 25.8 28.9 32.7 33.0 60.6 66.8 70.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Torrent Pharma 2QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   WYETH  TTK HEALTHCARE  ORCHID PHARMA  ALKEM LABORATORIES  SUVEN LIFESCIENCES  

Compare TORRENT PHARMA With:   WYETH  TTK HEALTHCARE  ORCHID PHARMA  ALKEM LABORATORIES  SUVEN LIFESCIENCES  

Compare TORRENT PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Jumped 505 Points Today(Closing)

Indian share markets continued momentum and ended their session on a strong note today.

Views on news

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Is this Sector the Best Contrarian Bet Right Now? (Profit Hunter)

Nov 23, 2020

The risk reward ratio in this beaten down sector may have finally turned for the better.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Dec 1, 2020 03:36 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - FRESENIUS KABI ONCO. COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS